Viemed Healthcare
VMD

$7.42

1.98%

Market Cap: 288M

About: Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

Employees: 1,030

Healthcare Miscellaneous Health & Allied Services

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

29% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 28

18% more capital invested

Capital invested by funds: $197M [Q4 2023] → $233M (+$36.2M) [Q1 2024]

10% more funds holding

Funds holding: 102 [Q4 2023] → 112 (+10) [Q1 2024]

1.32% less ownership

Funds ownership: 65.16% [Q4 2023] → 63.84% (-1.32%) [Q1 2024]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 1 (-1) [Q1 2024]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for VMD.

See Analyst Rankings

Financial journalist opinion

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 8, 2024 at 11:00 a.m. ET.

Viemed Healthcare Announces Date and Time for Conference Call

Viemed Healthcare, Inc. (VMD) Q1 2024 Earnings Call Transcript

Viemed Healthcare, Inc. (NASDAQ:VMD ) Q1 2024 Earnings Conference Call May 7, 2024 11:00 AM ET Company Participants Todd Zehnder – COO Casey Hoyt - CEO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Alexander Graf - Riva Ridge capital Jeffrey Bronchick - Cove Street Capital Operator Greetings, and welcome to the Viemed First Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

Viemed Healthcare, Inc. (VMD) Q1 2024 Earnings Call Transcript

Viemed Healthcare Announces First Quarter 2024 Financial Results

LAFAYETTE, La., May 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2024.

Viemed Healthcare Announces First Quarter 2024 Financial Results

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, La., April 23, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Tuesday, May 7, 2024 at 11:00 a.m. ET.

Viemed Healthcare Announces Date and Time for Conference Call

Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health

LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health (“EAH”), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama.

Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health

Viemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call Transcript

Viemed Healthcare, Inc. (NASDAQ:VMD ) Q4 2023 Earnings Conference Call March 7, 2024 11:00 AM ET Company Participants Todd Zehnder - COO Casey Hoyt - CEO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Eric Coldwell - Baird Operator Greetings, and welcome to the Viemed Fourth Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

Viemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call Transcript

Viemed Healthcare Announces Record 2023 Financial Results

LAFAYETTE, La., March 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2023.

Viemed Healthcare Announces Record 2023 Financial Results

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, La., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Year End Conference Call on Thursday, March 7, 2024 at 11:00 a.m. ET.

Viemed Healthcare Announces Date and Time for Conference Call

Viemed to Centralize Market for Common Shares on NASDAQ Through Voluntary Delisting from TSX

LAFAYETTE, La., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has applied and received approval from the Toronto Stock Exchange (“TSX”) for the voluntary delisting of its common shares (each a “Common Share”) from the TSX. The delisting from TSX will not affect the Company's listing on the NASDAQ Capital Market ("NASDAQ").

Viemed to Centralize Market for Common Shares on NASDAQ Through Voluntary Delisting from TSX

See News Rankings